Journals / Koşuyolu Heart Journal / 2018 / Cilt: 21 - Sayı: 2

Experience at a Tertiary Center and Short-term Results in Carotid Artery Stent Implantation

Karotis Artere Stent Yerleştirme İşleminde Tersiyer Merkez Deneyimi ve Kısa Dönem Sonuçlar

Pages
93–97
Publication Date
2018-08-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: CAS placement can be safely performed with low major adverse cerebrovascular events and high success rates in symptomatic or asymptomatic patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Patients with carotid artery stenosis are at increased risk for stroke and cardiovascular death.
📊
Key Findings & Data:Patients and Methods: Totally, 220 patients [169 males, 51 females; median age, 66 (45-83) years] who underwent carotid artery stent (CAS) placement were included in the study.
💡
Conclusion & Impact:Conclusion: CAS placement can be safely performed with low major adverse cerebrovascular events and high success rates in symptomatic or asymptomatic patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Karotis arter hastalığı · karotis arter stentleme · iskemik inme

Abstract

Introduction: Patients with carotid artery stenosis are at increased risk for stroke and cardiovascular death. Here, we aimed to present the short-term results of carotid artery endovascular procedures performed at our tertiary center. Patients and Methods: Totally, 220 patients [169 males, 51 females; median age, 66 (45-83) years] who underwent carotid artery stent (CAS) placement were included in the study. Post-procedural myocardial infarction (MI); major adverse events, including stroke and death; and procedural hypotension and transient cerebral ischemic events were evaluated in the 1-month period. Results: Totally, 231 carotid stenoses and stents were implanted in all patients. Eleven patients (5%) were treated using staged CAS owing to bilateral carotid artery disease. The technical success rate was 97%. One (0.4%) patient died; however, no MI was observed during successful CAS implantation. Two patients (0.9%) developed ischemic cerebrovascular events 24 hours after the procedure. Totally, 5 patients (2.2%) had a transient ischemic attack in the 1-month period after the procedure. Eight patients (3.6%) developed procedural hypotension. No patient had hyperperfusion syndrome. Conclusion: CAS placement can be safely performed with low major adverse cerebrovascular events and high success rates in symptomatic or asymptomatic patients.

Özet

Giriş: Karotis arter darlığı olan hastalar inme ve kardiyovasküler ölüm açısından artmış risk altındadır. Bizim bu çalışmadaki amacımız, karotis artere endovasküler girişiminde tersiyer merkez olarak kısa dönem sonuçlarını sunmaktır. Hastalar ve Yöntem: Karotis artere stent yerleştirme (KAS) işlemi uygulanan 220 [169 erkek ve 51 kadın, ortanca yaş 66 (45-83)] hasta çalışmaya dahil edildi. Tüm olgularda distal koruma cihazı kullanıldı. İşlem sonrası bir aylık dönemdeki miyokart infarktüsü (Mİ), inme ve ölümü içeren majör advers olaylar ve işleme bağlı hipotansiyon ve geçici serebral iskemik olaylar değerlendirildi. Bulgular: İki yüz otuz bir karotis arter darlığına stent implantasyonu kararı verildi. On bir hasta (%5) bilateral karotis arter darlığı nedeniyle aşamalı KAS işlemi uygulandı. İşlem başarısı %97 bulundu. Başarılı şekilde KAS işlemi uyguladığımız 1 (%0.4) hastada ölüm gelişti ama hiçbirinde Mİ görülmedi. İki hastada (%0.9) işlemden 24 saat sonra sekelli iskemik serebrovasküler olay gelişti. Toplam 5 (%2.2) hastada işlem sonrası bir aylık dönemde geçici iskemik atak gözlendi. Sekiz (%3.6) hastada işleme bağlı hipotansiyon gelişti. Hiçbir hastada hiperperfüzyon sendromu yaşanmadı. Sonuç: KAS işleminin semptomlu veya semptomsuz hastalarda düşük majör advers serebrovasküler olaylar ve yüksek başarı oranları ile güvenli bir şekilde yapılabileceğini düşünmekteyiz.

🔖

Cite This Article

CERŞİT, S., ŞAHİN, M. (2018). Experience at a Tertiary Center and Short-term Results in Carotid Artery Stent Implantation. Koşuyolu Heart Journal, Cilt: 21 - Sayı: 2, 93–97. https://ajindex.com/articles/63879

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Aydıner O, Boztosun B, Sirvanci M, Akçakoyun M, Karaman K, Aksoy T, et al. Early and late outcomes of carotid artery stenting. Anadolu Kardiyol Derg 2007;7:152-7
  2. Moresoli P, Habib B, Reynier P, Secrest MH, Eisenberg MJ, Filion KB. Carotid stenting versus endarterectomy for asymptomatic carotid artery stenosis: a systematic review and meta-analysis. Stroke 2017;48:2150-7
  3. Meschia JF, Brott TG, Hobson RW. Diagnosis and invasive management of carotid atherosclerotic stenosis. Mayo Clin Proc 2007;82:851-8
  4. Brott TG, Hobson RW II, Howard G, Roubin GS, Clark WM, Brooks W, et al; CREST Investigators. Stenting versus endarterectomy for treatment of carotid-artery stenosis (CREST). N Engl J Med 2010;363:11-23. Erratum in: N Engl J Med 2010;363:498. N Engl J Med 2010;363:198
  5. Li Y, Yang JJ, Zhu SH, Xu B, Wang L. Long-term efficacy and safety of carotid artery stenting versus endarterectomy: A meta-analysis of randomized controlled trials. PLoS One 2017;12:e0180804
  6. Arhuidese IJ, Rizwan M, Nejim B, Malas M. Outcomes of primary and secondary carotid artery stenting. Stroke 2017;48:3086-92
  7. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD; Joint ESC/ACCF/AHA/WHF Task Force for Universal Definition of Myocardial Infarction; Authors/Task Force Members Chairpersons, Thygesen K, Alpert JS, White HD; Biomarker Subcommittee, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA; ECG Subcommittee, Chaitman BR, Clemmensen PM, Johanson P, Hod H; Imaging Subcommittee, Underwood R, Bax JJ, Bonow JJ, Pinto F, Gibbons RJ; Classification Subcommittee, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW; Intervention Subcommittee, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasche P, Ravkilde J; Trials & Registries Subcommittee, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML; Trials & Registries Subcommittee, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G; Trials & Registries Subcommittee, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D; Trials & Registries Subcommittee, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S; ESC Committee for Practice Guidelines (CPG), Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S; Document Reviewers, Morais J, Aguiar C, Almahmeed W, Arnar DO, Ba